Posted in | News | Semiconductor

Zarlink Semiconductor Complete Acquisition of Voice ICs

Zarlink Semiconductor Inc. is pleased to announce that it has closed its previously announced acquisition of Legerity Holdings, Inc., a leading developer and supplier of voice ICs (integrated circuits) for carrier, enterprise and residential gateway equipment.

On July 30, 2007, Zarlink closed its offering of Cdn$75,000,000 principal amount of subscription receipts (the "Subscription Receipts"). As a result of the closing of the acquisition, the Subscription Receipts will be automatically exchanged, without payment of additional consideration, for Cdn$75,000,000 principal amount of convertible unsecured subordinated debentures (the "Convertible Debentures") on the basis of Cdn$1,000 principal amount of Convertible Debentures for each Cdn$1,000 principal amount of Subscription Receipts, effective at 5:00 p.m. (Toronto time) on August 3, 2007. The Convertible Debentures will be issued through the facilities of CDS. The Subscription Receipts had been trading on the Toronto Stock Exchange under the symbol "ZL.DB.R" and will be delisted at the close of business on August 7, 2007 and the Convertible Debentures will trade on the Toronto Stock Exchange under the symbol "ZL.DB" commencing at the open of business on August 8, 2007.

Zarlink will be issuing revised guidance for the second quarter Fiscal 2008 in the coming weeks.

As the Subscription Receipts were traded, and the Convertible Debentures will trade, in the book-entry system and no individual certificates have been or will be issued, holders of the Subscription Receipts need not take any action in order to receive the Convertible Debentures to which they are entitled. Customer confirmations with respect to these Convertible Debentures will be entered through the book-entry system no later than August 8, 2007.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.